Nuvectis licenses two clinical-stage compounds from Haisco
Go back to Nuvectis licenses two clinical-stage compounds from Haisco| (NASDAQ: NVCT) | Delayed: 23.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.56 | 52 Week High | $ | |||
| Open | $23.56 | 52 Week Low | $ | |||
| Day High | $23.56 | P/E | N/A | |||
| Day Low | $23.56 | EPS | $ | |||
| Volume | 1 | |||||
